Acquisition - February 4, 2015
Ginolis, Canadian Firm Ink Deal
Ginolis Ltd. has delivered a development and production solution for point-of- care diagnostic tests to a Canada-based company that is operating in international markets. The tests are used for assessing cardiac risks and are already available internationally. The Ginolis solution provides increased production capacity and improved quality control with which the customer can respond to […]
Uncategorized - February 4, 2015
Protein-Heart Failure Link Under Study
Scientists at the Centre for Protein Research at the University of Copenhagen are searching for a way to prevent heart failure by studying how proteins inside heart cells change during heart failure. Previous research has shown that some of these specific proteins are malfunctioning in patients with heart failure. Researchers have found that if a […]
In a new job - February 3, 2015
Karolinska Dev. CEO Out
Karolinska Development AB’s CEO Bruno Lucidi is leaving the company, according to a company announcement. He is being replaced by Development Deputy CEO Terje Kalland until a permanent CEO is named. The search for a permanent replacement already has begun. “The Board of Directors recognizes that the Board and Bruno Lucidi are of different opinions […]
Uncategorized - February 3, 2015
Scientists Catalog Proteins
Scientists have catalogued which proteins operate in each of the body’s 32 different types of tissue and what their functions are in relation to other types of tissue. The discovery will be useful in the development of medicines capable of targeting specific diseases, according to the scientists behind the study “The perspectives of mapping the […]
Uncategorized - February 2, 2015
FICHe Nurturing New Companies
European Union funded FICHe (Future Internet Challenge eHealth) accelerator program has selected 80 European health technology companies from more than 300 applications for the first phase of the project. Participation was open to all European eHealth small and mid-sized enterprises and startups looking to develop innovative applications in the eHealth domain using FIWARE technology. In […]
Pharma Business - February 2, 2015
Profits for Novo Nordisk in 2014
Novo Nordisk increased operating profit in local currencies by 13 percent and by 10 percent in Danish kroner to DKK 34.5 billion in 2014. Sales growth of 8 percent in local currencies was driven by increased sales of Levemir® and Victoza®. Sales also increased by 6 percent in Danish kroner to 88.8 billion. Gross margin improved […]
